GSK3beta signalling: casting a wide net in Alzheimer's disease
about
sameAs
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisClock Genes in Glia Cells: A Rhythmic HistoryA threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophreniaAlternate day fasting impacts the brain insulin-signaling pathway of young adult male C57BL/6 miceGSK3beta in ethanol neurotoxicityAmyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling.Local in vivo GSK3β knockdown promotes pancreatic β cell and acinar cell regeneration in 90% pancreatectomized ratRegion-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophreniaOverexpression of glycogen synthase kinase 3beta sensitizes neuronal cells to ethanol toxicityGlycogen-synthase kinase-3beta is decreased in peripheral blood mononuclear cells of patients with mild cognitive impairmentFragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons.Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's diseaseSuggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder.The Alzheimer's disease mitochondrial cascade hypothesis: an updateActivity-dependent regulation of dendritic growth and maintenance by glycogen synthase kinase 3βResveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death.Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage.Activation of glycogen synthase kinase 3beta promotes the intermolecular association of tau. The use of fluorescence resonance energy transfer microscopy.Effects of melatonin on wortmannin-induced tau hyperphosphorylation.Phospholipase C-independent activation of glycogen synthase kinase-3beta and C-terminal Src kinase by Galphaq.Neonatal growth and regeneration of beta-cells are regulated by the Wnt/beta-catenin signaling in normal and diabetic rats.FRAT1 peptide decreases Abeta production in swAPP(751) cells.Altered Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3β and β-catenin.Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?The Role of Mammalian Glial Cells in Circadian Rhythm Regulation.Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPOWWOX Phosphorylation, Signaling, and Role in Neurodegeneration
P2860
Q24651407-76CFFB11-D27E-4B99-A1C1-D64FE607E984Q28077975-E2FB1D0D-2DCC-48DF-99DC-3EE72A5D583BQ28302383-5E2C18F3-297D-427D-A691-751A39E054F6Q28386794-C219A7B7-B314-46AC-BA0A-FB56B6938E46Q28387181-251BC0D7-E1C6-4108-B28F-569B1E55E4E4Q29977753-631398AD-6A47-4B8F-A53D-2D3678EE9AC4Q34290057-AFBC68B5-74FF-4603-BB6D-29AEF39AC324Q34873914-A8AD0A32-941A-4DB2-B7C2-B7C34EF83AA3Q34903613-1E67F0A4-784C-4BCA-B408-BE0738F5C3DCQ35028865-DC33B5CA-B48E-4BF7-91EE-2610F9CD9DE6Q35087803-70A84503-85A8-47DC-B1C0-CC211BF9A446Q35610595-E054F170-AC9B-434B-AF3A-82030580481CQ35770186-3E4D5D7A-92E0-4CFB-A451-31819AB522D7Q36329594-5B68E2FC-B7B1-4BFC-910C-C03B57B236ECQ37118472-E5D6F654-6A5D-4D3E-B55A-96842C5D8FACQ37261159-FFFE0D78-858F-420E-BAC0-2FC8F88C1CF8Q37292338-8C553F5A-93E7-4D13-9653-E5E50B91D3A6Q37680244-A6BA9505-60A2-4531-9AD8-D6C431D320B6Q38170338-93373B6B-9635-483A-B5A5-DA5D1E38004DQ38266162-47B01D41-1F37-4169-8827-243E6E4F97A1Q39194419-8F29389A-6620-4C39-8025-1BD39298D9B1Q40073866-1ADE3CC4-B6CD-4B68-9E5C-8F71C1B9981BQ40120481-6977508F-8706-45B5-BD86-AB38EBE90F88Q40432890-A08294A1-0097-4F0F-9847-BE82678A0F88Q40625747-77A6F5B0-82A1-462D-B443-6EA922534EEDQ43240236-B72A7159-9DEB-4B09-886E-75EA84B6C514Q44627986-C6DF6421-50EA-4A1B-9DA7-0A39BA82E81AQ44899646-777BB6D4-F005-4715-B3D8-4518739D5C11Q47161596-4989BA5E-B3C4-45AF-B598-22A3A7C188C9Q49444195-54AB6207-E94C-48BB-8483-EB0500333DFAQ58751451-060B07A1-E3A5-4ABA-9054-13B5C772CB14Q58777445-5C413FF1-3618-4854-AB20-DB3CD27C612A
P2860
GSK3beta signalling: casting a wide net in Alzheimer's disease
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
GSK3beta signalling: casting a wide net in Alzheimer's disease
@ast
GSK3beta signalling: casting a wide net in Alzheimer's disease
@en
GSK3beta signalling: casting a wide net in Alzheimer's disease
@nl
type
label
GSK3beta signalling: casting a wide net in Alzheimer's disease
@ast
GSK3beta signalling: casting a wide net in Alzheimer's disease
@en
GSK3beta signalling: casting a wide net in Alzheimer's disease
@nl
prefLabel
GSK3beta signalling: casting a wide net in Alzheimer's disease
@ast
GSK3beta signalling: casting a wide net in Alzheimer's disease
@en
GSK3beta signalling: casting a wide net in Alzheimer's disease
@nl
P3181
P356
P1433
P1476
GSK3beta signalling: casting a wide net in Alzheimer's disease
@en
P2093
Ratan V Bhat
Samantha L Budd
P304
P3181
P356
10.1159/000067423
P407
P577
2002-01-01T00:00:00Z